STOP-HAE: A Phase 3 Study of ADX-324 in HAE

NCT06960213 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema
HAE
Hereditary Angioedema - Type 1
Hereditary Angioedema - Type 2

Interventions

DRUG: ADX-324
DRUG: Placebo

Sponsor

ADARx Pharmaceuticals, Inc.